1. Home
  2. PCVX vs CPA Comparison

PCVX vs CPA Comparison

Compare PCVX & CPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • CPA
  • Stock Information
  • Founded
  • PCVX 2013
  • CPA 1947
  • Country
  • PCVX United States
  • CPA Panama
  • Employees
  • PCVX N/A
  • CPA 7909
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • CPA Air Freight/Delivery Services
  • Sector
  • PCVX Health Care
  • CPA Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • CPA Nasdaq
  • Market Cap
  • PCVX 4.4B
  • CPA 4.3B
  • IPO Year
  • PCVX 2020
  • CPA 2005
  • Fundamental
  • Price
  • PCVX $33.27
  • CPA $111.17
  • Analyst Decision
  • PCVX Strong Buy
  • CPA Strong Buy
  • Analyst Count
  • PCVX 10
  • CPA 5
  • Target Price
  • PCVX $136.50
  • CPA $153.00
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • CPA 320.1K
  • Earning Date
  • PCVX 08-05-2025
  • CPA 08-06-2025
  • Dividend Yield
  • PCVX N/A
  • CPA 5.79%
  • EPS Growth
  • PCVX N/A
  • CPA 5.12
  • EPS
  • PCVX N/A
  • CPA 14.63
  • Revenue
  • PCVX N/A
  • CPA $3,451,912,000.00
  • Revenue This Year
  • PCVX N/A
  • CPA $5.54
  • Revenue Next Year
  • PCVX N/A
  • CPA $9.27
  • P/E Ratio
  • PCVX N/A
  • CPA $7.46
  • Revenue Growth
  • PCVX N/A
  • CPA N/A
  • 52 Week Low
  • PCVX $27.66
  • CPA $80.01
  • 52 Week High
  • PCVX $121.06
  • CPA $111.23
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.99
  • CPA 65.26
  • Support Level
  • PCVX $32.00
  • CPA $104.90
  • Resistance Level
  • PCVX $34.63
  • CPA $109.98
  • Average True Range (ATR)
  • PCVX 1.31
  • CPA 2.72
  • MACD
  • PCVX -0.08
  • CPA 0.32
  • Stochastic Oscillator
  • PCVX 37.46
  • CPA 98.59

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

Share on Social Networks: